U.S. Wireless Telecom Stock News

NYSE:ROL
NYSE:ROLCommercial Services

Will Double-Digit Revenue Growth And Higher EPS Estimates Change Rollins' (ROL) Narrative?

Rollins, Inc. recently reported a 10.2% year-over-year revenue increase that surpassed analyst expectations, even as EBITDA fell short, and is now preparing to release its second-quarter 2026 results on July 22 after the market close. An interesting angle is that analysts have raised their consensus EPS estimate by 1.7% over the past month, pointing to growing confidence in Rollins’ ability to convert revenue gains from acquisitions, market expansion, and pricing initiatives into...
NasdaqGS:MRVL
NasdaqGS:MRVLSemiconductor

Marvell Technology (MRVL) Rebounds With AI Optimism While Valuation Questions Linger

Marvell Technology (MRVL) moved higher as semiconductor stocks rebounded, with investors responding to improving sentiment around artificial intelligence spending and looking ahead to a packed stretch of technology earnings after recent sector volatility. See our latest analysis for Marvell Technology. At a share price of US$194.94, Marvell Technology has seen short term momentum cool, with a 1 month share price return down 37.23% and a 7 day share price return down 10.38%. However, the 1...
NYSE:BRK.A
NYSE:BRK.ADiversified Financial

Berkshire Hathaway (BRK.A) Could Be 22% Undervalued After Buffett’s 2034 Donation Plan

Buffett’s $140 billion exit plan reshapes Berkshire’s ownership picture Warren Buffett’s decision to donate his entire roughly $140 billion Berkshire Hathaway (BRK.A) stake by 2034, including recent large Class A to Class B conversions, is reshaping the company’s long term ownership profile for investors. See our latest analysis for Berkshire Hathaway. Against the backdrop of Buffett’s planned share donations and Berkshire Hathaway’s growing focus on concentrated holdings such as Apple and...
NYSE:DK
NYSE:DKOil and Gas

Is Delek US (DK) Reframing Its Profit Story Through the Enterprise Optimization Plan’s Early Wins?

In recent days, Delek US Holdings’ Enterprise Optimization Plan has begun to show clearer operational benefits, prompting analysts to lift earnings estimates and reflect stronger confidence in the company’s profitability outlook. This shift highlights how concrete cash-flow improvement targets and visible execution progress can materially reshape perceptions of a refiner’s longer-term earnings power and business mix. We will now explore how the early success of Delek’s Enterprise...
NasdaqGS:LIVN
NasdaqGS:LIVNMedical Equipment

LivaNova (LIVN) And The Narrative Behind Its Undervalued View

LivaNova (LIVN) has drawn investor attention after a recent move in the stock, with returns over the past 3 months and year contrasting with softer daily and weekly performance. See our latest analysis for LivaNova. The recent pullback, with a 1-day share price return of 1.85% and a 7-day share price return of 4.54%, sits against stronger momentum. This includes a 90-day share price return of 22.75% and a 1-year total shareholder return of 87.04%, indicating that longer term gains have been...
NasdaqGS:OZK
NasdaqGS:OZKBanks

Bank OZK (OZK) Expands Equipment Finance Reach, Is The Stock Fairly Valued?

Empire Asset Finance has closed its first institutional warehouse credit facility with Bank OZK (OZK), highlighting the bank’s push into equipment financing and potential implications for its lending mix to middle-market clients. See our latest analysis for Bank OZK. At a share price of $51.43, Bank OZK has seen its momentum build recently, with a 30 day share price return of 4.41% and a year to date share price return of 9.33%. Its 5 year total shareholder return of 48.86% reflects a longer...
NYSE:MLI
NYSE:MLIMachinery

Mueller Industries (MLI) Following A 14% Drop, Is It Still A Bargain?

Mueller Industries (MLI) has drawn fresh attention after recent share price moves, with the stock down about 14% over the past month and roughly 12% over the past 3 months, compared with a longer-term gain profile. See our latest analysis for Mueller Industries. At around $58.97, Mueller Industries’ 1 month share price return is down 14.2% and its 3 month share price return is down 12.5%, even though the 1 year total shareholder return sits at about 42.9% and the 5 year total shareholder...
NasdaqGS:LFST
NasdaqGS:LFSTHealthcare

How LifeStance’s Board and Committee Shake-Up Will Impact LifeStance Health Group (LFST) Investors

On July 2, 2026, LifeStance Health Group announced that director Jeffrey Rhodes resigned from the board and its committees, while three new directors, Thurman Justice, Lori Goltermann, and Safwan Shabab, were appointed with defined terms and committee roles. The addition of three directors with specific responsibilities across audit, quality and compliance, compensation, and governance committees signals a meaningful refresh of LifeStance’s oversight structure and potential shifts in...
NYSE:COHR
NYSE:COHRElectronic

Is Coherent (COHR) Undervalued As AI Infrastructure Optimism Lifts The Stock?

Coherent (COHR) stock moved higher as semiconductor and AI infrastructure companies attracted renewed interest, even while escalating U.S. Iran tensions pressured major indices and prompted investors to reassess how this tech supplier fits into evolving AI demand. See our latest analysis for Coherent. Coherent’s recent 2.81% 1 day share price gain to US$285.40 comes after a sharp 26.74% share price decline over the past 30 days. Its very large 3 year total shareholder return suggests longer...
NYSE:BX
NYSE:BXCapital Markets

Blackstone (BX) Could Be 14% Undervalued On Its Ode AI Push

Blackstone (BX) is back in focus after helping launch Ode with Anthropic, an AI services company backed by a global investor consortium. This has raised fresh questions about how its growing AI exposure might influence the stock. See our latest analysis for Blackstone. Recent moves into AI services sit against a weaker share price backdrop, with Blackstone’s share price down 22.16% year to date and its 1 year total shareholder return down 23.15%. However, the 3 year total shareholder return...
NasdaqGM:HROW
NasdaqGM:HROWPharmaceuticals

Can New Retina Data Deepen Harrow’s (HROW) Moat In Ophthalmology Or Just Refine Its Story?

Harrow recently highlighted three new clinical and real-world studies for its retina portfolio at the 2026 ASRS Annual Meeting, including interim randomized data and a nearly 20,000‑injection safety analysis for IHEEZO, plus interim post‑marketing findings for BYOOVIZ from Samsung Bioepis. The early signals of improved post‑injection patient experience with IHEEZO, alongside large‑scale safety data and expanding evidence for BYOOVIZ, strengthen the clinical underpinnings of Harrow’s retina...
NasdaqGS:ZION
NasdaqGS:ZIONBanks

How Investors May Respond To Zions (ZION) Q2 Results And New Leadership In Idaho Corporate Banking

Zions Bancorporation National Association recently reported its second-quarter earnings, following earlier expectations for higher year-on-year earnings per share and steady revenue growth. Alongside these earnings, the recent additions of Daniel J. Ryan to the board and Flip Kleffner to lead Idaho corporate banking highlight governance and regional commercial banking focus that could influence how investors view Zions’ longer-term positioning. We’ll now examine how the anticipated earnings...
NYSE:DTE
NYSE:DTEIntegrated Utilities

DTE Energy (DTE) Pulls Back On Grid Growth Story, Is The Stock Still Cheap?

DTE Energy (DTE) stock is back in focus after recent trading pressure, with the share price down 1.5% over the past day and 3.1% over the past week, prompting fresh interest in its fundamentals. See our latest analysis for DTE Energy. Stepping back from the recent pullback, DTE Energy’s 11.96% year to date share price return and 9.37% 1 year total shareholder return point to momentum that has cooled slightly in the very short term as investors reassess risk and income prospects around the...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

Vertex Pharmaceuticals (VRTX) Stock Trades Below Fair Value After Deal Plans

Vertex Pharmaceuticals stock has delivered a 141.5% return over the past 5 years, and the latest intrinsic value work using a Discounted Cash Flow (DCF) approach now points to the shares trading at a discount to that estimate, even as the broader valuation checks look more mixed. With the market pricing in both the planned Crinetics Pharmaceuticals acquisition and ongoing revenue from existing partnerships, investors are weighing whether the current price still leaves enough cushion. A...
NasdaqGM:IRMD
NasdaqGM:IRMDMedical Equipment

IRADIMED (IRMD) As MRI Pump Upgrade Narrative Points To Fair Value Above The Stock

IRADIMED stock snapshot after recent performance IRADIMED (IRMD) has drawn fresh attention after a period of steady trading, with the stock flat over the past day while showing gains over the past month and past 3 months. See our latest analysis for IRADIMED. At a share price of $97.03, IRADIMED has seen a 30 day share price return of 5.24% and a 1 year total shareholder return of 75.09%. This suggests recent momentum has built on already strong longer term gains. If IRADIMED's move has...
NYSE:DFIN
NYSE:DFINCapital Markets

Donnelley Financial Solutions (DFIN) Rebounds In Focus, Is The Stock Still Cheap?

Donnelley Financial Solutions (DFIN) has drawn fresh attention after recent trading left the stock with a mixed return profile, including a gain over the past month but a decline across the past 3 months. See our latest analysis for Donnelley Financial Solutions. The 1-month share price return of 25.27% for Donnelley Financial Solutions contrasts with a 1-year total shareholder return that is down 19.92%. This suggests that recent momentum has picked up following a weaker period. If you want...
NasdaqGS:HON
NasdaqGS:HONIndustrials

Honeywell International (HON) Could Be 29% Below Fair Value After Lowered Earnings Expectations

Honeywell International (HON) has reaffirmed its 2026 sales outlook and detailed earnings guidance that separates the impact of its Aerospace Technologies spin off, putting the stock’s post breakup profit profile under closer investor review. See our latest analysis for Honeywell International. Despite reaffirmed 2026 guidance and the Aerospace Technologies spin off, Honeywell International’s recent share price performance has been weak, with the 30 day share price return declining 50.62% and...
NasdaqGS:COST
NasdaqGS:COSTConsumer Retailing

Costco Wholesale (COST) Could Be 14% Undervalued Following Fresh Product Launches

Costco Wholesale (COST) has come back into focus after a cluster of partner announcements, with Laifen, Jackery and Tick Solutions all choosing the membership retailer for new or exclusive product launches across U.S. warehouses and Costco.com. See our latest analysis for Costco Wholesale. Despite the fresh product partnerships and steady operational news, Costco Wholesale’s recent 90 day share price return is down 6.96%, while the year to date share price return is 9.51% and the 5 year total...
NYSE:CRM
NYSE:CRMSoftware

Salesforce’s Major U.S. Air Force Deal Might Change The Case For Investing In Salesforce (CRM)

Earlier this month, Salesforce announced that the U.S. Air Force’s 441st Vehicle Support Chain Operations Squadron adopted Missionforce National Security on Government Cloud Plus Defense to manage a US$13.50 billion fleet of over 84,000 vehicles across nearly 389 locations with IL5-authorized, real-time logistics and analytics tools. This deployment offers a concrete example of how Salesforce’s government-grade platform and AI-ready data foundation can support complex, high-stakes...
NYSE:LLY
NYSE:LLYPharmaceuticals

The Bull Case For Eli Lilly (LLY) Could Change Following Its Deeper Role In Illumina’s Billion Cell Atlas

In January 2026, Illumina announced the launch of its Billion Cell Atlas alliance, naming Eli Lilly as a founding member in a program that uses CRISPR-based, large-scale genomic perturbation data and AI to map disease biology across more than 200 cell lines and hundreds of cell types. By mid-July 2026, the Atlas had already sequenced over 350 million cells and generated several petabytes of data, positioning Lilly closer to the core of AI-driven target discovery and mechanistic insights for...
NYSE:PLNT
NYSE:PLNTHospitality

Planet Fitness (PLNT) Stock Could Be 42% Undervalued On Class Action Fallout

Planet Fitness stock is in an unusual spot for investors, with the share price down sharply over the past year while both a Discounted Cash Flow (DCF) intrinsic value estimate and earnings based multiples point to the shares trading at a discount to their implied worth. Over the last 12 months, Planet Fitness shares have declined 49.8%, which puts recent valuation concerns firmly in focus for anyone already holding or considering the stock. Recent concerns around slower membership growth, a...
NasdaqGS:FIBK
NasdaqGS:FIBKBanks

Is New Board Talent and GC Exit Altering The Investment Case For First Interstate (FIBK)?

First Interstate BancSystem, Inc. recently expanded its Board by appointing Matthew Ritter and Kevin Turner as independent Class II directors through the 2029 annual meeting, while also involuntarily and without cause terminating Executive Vice President and General Counsel/Corporate Secretary Kirk D. Jensen on July 9, 2026. The arrival of two high-profile, independent directors with deep finance, technology, and operational backgrounds alongside the sudden departure of the General Counsel...
NYSE:MA
NYSE:MADiversified Financial

Does Mastercard’s New Interchange-Fee Surcharge Flexibility Reshape the Bull Case for MA?

Earlier this month, Mastercard reached a settlement with Visa over credit card interchange fees, giving merchants the option to add surcharges of up to 3% on premium and commercial card transactions to better recoup their processing costs. This marks a meaningful shift in how costs are shared across the payments chain and could influence how merchants and consumers choose which cards to use. Next, we’ll examine how this interchange-fee settlement, especially the new merchant surcharge...
NYSE:HIG
NYSE:HIGInsurance

Hartford (HIG) Appoints Randy Larsen To Its Board After AssuredPartners Leadership

Hartford Insurance Group (NYSE:HIG) has appointed Randy Larsen to its Board of Directors. Larsen brings extensive insurance sector leadership experience, including his tenure as CEO of AssuredPartners. The appointment adds operational and transaction experience in both organic expansion and acquisitions to the board. For investors following Hartford Insurance Group, the board appointment of Randy Larsen highlights an effort to deepen insurance operating experience at the governance level...